We observed a marked increase in apoptosis in BLCA cells following knockdown of FASN or RUNX2, indicating that both genes may promote tumor growth by conferring anti-apoptotic advantages (Figures 9E–H, Supplementary Figures 7E-H). The gene discussed is FASN; the disease is bladder transitional cell carcinoma.